Newborn Persistent Hypoglycemia Clinical Pathway — N/IICU
Medications for HI
Use these medications after consultation with and under guidance of Pediatric Endocrinology.
Medication | Action/Dose | Side Effects |
---|---|---|
Diazoxide |
Beta cell KATP channel activator leads to inhibition of insulin secretion
|
|
Glucagon infusion |
|
|
Medications NOT Recommended
Octreotide |
|
|
---|---|---|
Glucocorticoids |
|
|
Nifedipine |
|
|